Sex differences in mortality after percutaneous coronary intervention: a contemporary nationwide registry and

Kittipong Pinyosamosorn1, Songsak Kiatchoosakun2, Sasiporn Sitthisorn3

  • 1Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Maharat Nakhonratchasima Hospital, Nakhon Ratchasima, Thailand.

PubMed

Insights

Women face higher in-hospital mortality after percutaneous coronary intervention (PCI). Specific conditions like chronic kidney disease and cardiogenic shock disproportionately increase mortality risk in women, highlighting a need for tailored care.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Sex-Based Medicine

Background:

  • Coronary artery disease (CAD) is a leading cause of death globally.
  • Women experience higher mortality rates post-percutaneous coronary intervention (PCI) compared to men.
  • Existing data on sex-specific risk factors and mortality following PCI is limited.

Purpose of the Study:

  • To evaluate in-hospital mortality rates after PCI.
  • To identify and analyze sex-specific risk factors associated with PCI outcomes.
  • To investigate disparities in mortality between men and women undergoing PCI.

Main Methods:

  • Analysis of a national PCI registry (19,701 patients).
  • Stratification of the patient cohort by sex.
  • Multivariable regression models to assess risk factors for in-hospital mortality.

Main Results:

  • Women had a higher in-hospital mortality rate (3.5%) than men (2.3%).
  • Chronic kidney disease (CKD), cerebrovascular disease, and cardiogenic shock (CS) significantly increased mortality risk exclusively in women.
  • Factors like emergency PCI, urgent PCI, and new dialysis requirement showed a more pronounced association with mortality in women compared to men.

Conclusions:

  • Women undergoing PCI exhibit significantly higher in-hospital and one-year mortality rates.
  • Stroke history, CS, and CKD are key mortality risk factors in women post-PCI.
  • Enhanced awareness and tailored peri-procedure care are crucial for improving outcomes in women.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
207
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
210
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
785
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580